Quantitative efficacy of L-carnitine supplementation on glycemic control in type 2 diabetes mellitus patients.
L-carnitine supplementation
Quantitative efficacy
fasting plasma glucose
glycated hemoglobin
glycemic control
type 2 diabetes mellitus
Journal
Expert review of clinical pharmacology
ISSN: 1751-2441
Titre abrégé: Expert Rev Clin Pharmacol
Pays: England
ID NLM: 101278296
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
pubmed:
17
4
2021
medline:
27
8
2021
entrez:
16
4
2021
Statut:
ppublish
Résumé
This study aimed to explore the quantitative efficacy of L-carnitine supplementation on glycemic control in type 2 diabetes mellitus patients using model-based meta-analysis (MBMA). Literatures were retrieved from the public database and data from these trials were extracted. The quantitative efficacy of L-carnitine on fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c) in type 2 diabetes mellitus patients were evaluated by maximal effect (E In the model of FPG, E It was the first time to provide valuable quantitative information for efficacy of L-carnitine supplementation on glycemic control in type 2 diabetes mellitus patients.
Identifiants
pubmed: 33861163
doi: 10.1080/17512433.2021.1917381
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Carnitine
S7UI8SM58A
Types de publication
Journal Article
Meta-Analysis
Review
Langues
eng
Sous-ensembles de citation
IM